Pathogenesis of ankylosing spondylitis: recent advances
Khan, M.A.
Journal of Rheumatology 20(8): 1273-1277
1993
ISSN/ISBN: 0315-162X PMID: 8230005 Document Number: 413062
Document emailed within 1 workday
Related Documents
Grazio, S.; Grubisić, F.; Nemcić, T.; Matijević, V.; Skala, H. 2009: The reliability and validity of a Croatian version of the Bath Ankylosing Spondylitis Functional Index (BASFI) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) in patients with ankylosing spondylitis Reumatizam 56(2): 63-76Sieper, J.; Braun, J. 2002: New treatment strategies in ankylosing spondylitis: Proceedings of the Ankylosing Spondylitis Workshop, Berlin, Germany, 18-19 January 2002 Annals of the Rheumatic Diseases 61 Suppl. 3: Iii1-Iii2
Chou, C.T. 2001: Factors affecting the pathogenesis of ankylosing spondylitis Chinese Medical Journal 114(2): 211-212
Bluestein, H.G. 1988: Anatomic and genetic considerations in the pathogenesis of ankylosing spondylitis Journal of Rheumatology. Suppl 16: 29-32
Villa Alcázar, L.F.; de Buergo, M.; Rico Lenza, H.; Montull Fruitós, E. 1996: Aceclofenac is as safe and effective as tenoxicam in the treatment of ankylosing spondylitis: a 3 month multicenter comparative trial. Spanish Study Group on Aceclofenac in Ankylosing Spondylitis Journal of Rheumatology 23(7): 1194-1199
Kim, T.-J.; Shin, J.-H.; Sung, I.-H.; Lee, S.; Song, Y.; Kim, T.-H. 2016: Comparison on radiographic progression for 5 years between juvenile onset ankylosing spondylitis and adult onset ankylosing spondylitis: an observational study of the Korean SpondyloArthropathy Registry (OSKAR) data Clinical and Experimental Rheumatology 34(4): 668-672
Calin, A.; Garrett, S.; Whitelock, H.; Kennedy, L.G.; O'Hea, J.; Mallorie, P.; Jenkinson, T. 1994: A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index Journal of Rheumatology 21(12): 2281-2285
Heldmann, F.; Brandt, J.; van der Horst-Bruinsma, I.E.; Landewe, R.; Sieper, J.; Burmester, G.R.; van den Bosch, F.; de Vlam, K.; Geusens, P.; Gaston, H.; Schewe, S.; Appelboom, T.; Emery, P.; Dougados, M.; Leirisalo-Repo, M.; Breban, M.; Listing, J.; Braun, J. 2011: The European ankylosing spondylitis infliximab cohort (EASIC): a European multicentre study of long term outcomes in patients with ankylosing spondylitis treated with infliximab Clinical and Experimental Rheumatology 29(4): 672-680
Menkes, C.J.; Kahan, A.; Feldmann, J.L.; Vinh, T. 1983: Destructive cervical spondylitis. An unusual initial manifestation of ankylosing spondylitis Presse Medicale 12(4): 227-229
Costa, T.; Falcão, S.; Mateus, M.; Branco, J. 2018: More than Ankylosing Spondylitis Acta Reumatologica Portuguesa 2018
Jajić, Z. 2000: Ankylosing spondylitis Reumatizam 47(2): 18-19
Saraux, A. 2011: Ankylosing spondylitis La Revue du Praticien 61(7): 999-1006
Gran, J.T.; Husby, G. 1987: On the prevalence of ankylosing spondylitis Journal of Rheumatology 14(1): 174-175
Fu, X.; Wang, J.C.; Jia, Y.M.; Kang, Q.; An, J.B. 1989: Ten families of ankylosing spondylitis Chinese Medical Journal 102(9): 709-712
Halsey, J.P.; Fitzcharles, M.A.; Currey, H.L. 1981: Piroxicam in ankylosing spondylitis European Journal of Rheumatology and Inflammation 4(3): 364-367
Sany, J.; Panis, G.; Seignalet, J.; Serre, H. 1979: Ankylosing spondylitis without HL-A B27 antigens La Nouvelle Presse Medicale 8(44): 3663-3664
Elyan, M.; Khan, M.Asim. 2006: Diagnosing ankylosing spondylitis Journal of Rheumatology. Supplement 78: 12-23
Van der Linden, S.M.; Cats, A.; Valkenburg, H.A. 1988: On the prevalence of ankylosing spondylitis Journal of Rheumatology 15(2): 375-377
Russell, A.S. 1979: The prevalence of ankylosing spondylitis Journal of Rheumatology 6(6): 603-605
Calin, A.; Edmunds, L.; Kennedy, L.G. 1993: Fatigue in ankylosing spondylitis--why is it ignored? Journal of Rheumatology 20(6): 991-995